Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07357818 · ClinicalTrials.gov registry record · NA
Effects of Caffeinated Beverages on Well-being
A NA study of Healthy and Caffeine, sponsored by Guayaki Sustainable Rainforest Products.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07357818: Recruiting NA study of Healthy and Caffeine, sponsored by Guayaki Sustainable Rainforest Products.
NCT07357818 is a NA study of Healthy and Caffeine that is actively recruiting participants, run by Guayaki Sustainable Rainforest Products. The registered enrollment target is 150 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07357818, a NA study of Healthy and Caffeine, is actively recruiting participants, sponsored by Guayaki Sustainable Rainforest Products.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.
Primary Outcome
Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
Conditions Studied
Interventions
- OTHER Participants' typical caffeinated beverage
- OTHER Test caffeinated beverage
Study Locations (1)
California
- Alethios, Inc. - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-11-03 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT07357818 shows while recruiting
NCT07357818 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Participants' typical caffeinated beverage is the first listed.
NCT07357818 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07357818 about?
NCT07357818 is a clinical study titled "Effects of Caffeinated Beverages on Well-being". This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.
What is the current status of trial NCT07357818?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-11-03. Estimated completion is 2026-04.
What conditions does trial NCT07357818 study?
This clinical trial studies the following conditions: Healthy, Caffeine, Beverage Intake.
What interventions are being tested in trial NCT07357818?
The interventions under investigation include: Participants' typical caffeinated beverage (OTHER), Test caffeinated beverage (OTHER).
Who is sponsoring clinical trial NCT07357818?
This trial is sponsored by Guayaki Sustainable Rainforest Products, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07357818 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07357818's enrollment target sits among peer trials
150 152nd of 1090 higher than 935 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI